Dr. Charles Morrow

Dr. Charles Morrow

Scientific Review Officer


Division of Basic and Integrative Biological Sciences DBIB
Review Branch:
Basic and Translational Cancer BTC
Study Section:
Cancer Cell Biology CCB

Dr. Charles Morrow received a Ph.D. in biochemistry from Saint Louis University and an M.D. from University of Missouri-Columbia. He completed training in pediatrics at Duke University and in pediatric hematology/oncology at the National Cancer Institute. Prior to joining CSR, Dr. Morrow was professor of biochemistry at Wake Forest University School of Medicine, where his research explored the roles of ABC efflux transporters and phase II metabolizing enzymes in cancer drug resistance, xenobiotic detoxification, chemoprevention, and electrophilic lipid signaling.


Last updated: 06/06/2024 14:32